当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2019年第22期
编号:13414943
MicroRNAs在糖尿病溃疡愈合中作用的研究进展(5)
http://www.100md.com 2019年8月5日 《中国医药导报》 2019年第22期
     [26] Sundaram GM,Common JE. “See-saw” expression of microRNA-198 and FSTL1 from a single transcript in wound healing [J]. Nature,2013,495(7439):103-106.

    [27] Lucas T,Schafer F. Light-inducible antimiR-92a as a therapeutic strategy to promote skin repair in healing-impaired diabetic mice [J]. Nat Commun,2017,8:15 162.

    [28] Liu J,Xu Y. Quantification of the differential expression levels of microRNA-203 in different degrees of diabetic foot [J]. Int J Clin Exp Pathol,2015,8(10):13 416-13 420.

    [29] Moura J,S?覬rensen A. MicroRNA-155 inhibition restores fibroblast growth factor 7 expression in diabetic skin and decreases wound inflammation [J]. Sci Rep,2019,9(1):5836.

    [30] Ghai V,Wang K. Recent progress toward the use of circulating microRNAs as clinical biomarkers [J]. Arch Toxicol,2016,90(12):2959-2978.

    [31] Zomer HD,Trentin AG. Skin wound healing in humans and mice:challenges in translational research [J]. J Dermatol Sci,2018,90(1):3-12.

    (收稿日期:2019-05-03 本文編辑:李亚聪), 百拇医药(邢烨 袁娜 韩睿)
上一页1 2 3 4 5